Epetraborole
REBOUND Trial
Phase 2 small_molecule active
Quick answer
Epetraborole for Mycobacterium Abscessus Infection is a Phase 2 program (small_molecule) at AN2 Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AN2 Therapeutics
- Indication
- Mycobacterium Abscessus Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active